Recombinant Human monoclonal antibody expressed in CHO binding to Human DDR1. This is an antibody that specifically binds to the extracellular domain of human discoidin domain receptor 1 (DDR1) outside the discoidin domain, and which reduces or blocks collagen- induced autophosphorylation of DDR1 without preventing collagen binding to DDR1. Discoidin domain receptor 1 (DDR1) is a receptor tyrosine kinase that is a promising therapeutic target for a number of aggressive cancers.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
PABL-436 | Mouse Anti-DDR1 Recombinant Antibody (clone mAb 3E3) | ELISA, FC | Mouse IgG |
MOB-1224CT | Recombinant Mouse anti-Human DDR1 Monoclonal antibody (3H5F23) | ELISA, IHC-P, WB | |
ZG-0475F | Mouse Anti-DDR1 Recombinant Antibody (ZG-0475F) | WB, ELISA | Mouse IgG |
VS-0723-WK89 | Human Anti-DDR1 Recombinant Antibody (VS-0723-WK89) | FC | Chimeric (rabbit/human) IgG1 |
VS3-WK2188 | Rabbit Anti-DDR1 (pY513) Recombinant Antibody (VS3-WK2188) | WB, ELISA | Rabbit IgG |
There are currently no Customer reviews or questions for TAB-211CL. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.